Biogen INC BIOGEN INC ORD SHS
Biogen INC BIOGEN INC ORD SHS/ US09062X1037 /
0R1B
5/24/2024 6:25:10 PM
|
Chg.
-
|
Volume |
Bid6:00:04 AM |
Ask6:00:04 AM |
Market Capitalization |
Dividend Y. |
P/E Ratio |
218.75USD
|
-
|
1,014 Turnover: 110,398.48 |
-Bid Size: - |
-Ask Size: - |
32.85 bill.USD |
- |
28.14 |
Fundamentals
|
FY 2023 |
Growth (1Y) |
Per Share |
|
Earnings per Share: |
8.02 USD |
-61.74% |
EPS Diluted: |
7.97 USD |
-61.81% |
Revenues per Share: |
67.66 USD |
-3.90% |
Book Value per Share: |
101.81 USD |
9.87% |
Cash Flow per Share: |
10.64 USD |
11.09% |
Dividend per Share: |
- USD |
- |
Total |
in mill. |
|
Revenues: |
9,835.60 USD |
-3.32% |
Net Income: |
1,161.10 USD |
-61.89% |
Operating Cash Flow: |
1,547.20 USD |
- |
Cash and Cash Equivalents: |
1,049.90 USD |
- |
Valuation Ratios
|
Current |
Latest FY* |
P/E Ratio: |
28.14 |
32.27 |
P/S Ratio: |
3.33 |
3.82 |
P/BV ratio: |
2.22 |
2.54 |
P/CF Ratio: |
21.20 |
24.31 |
PEG: |
-0.46 |
-0.52 |
Earnings Yield: |
3.55% |
3.10% |
Dividend Yield: |
- |
- |
Market Capitalization |
|
Market Capitalization: |
32.85 bill. USD |
37.62 bill. USD |
Free Float Market Cap.: |
- USD |
- USD |
Market Cap. / Employee: |
- USD |
- USD |
Shares Outstanding: |
145.6 mill. |
|
Profitability
Gross Profit Margin: |
74.24% |
EBIT Margin: |
0.00% |
Net Profit Margin: |
11.81% |
Return on Equity: |
7.85% |
Return on Assets: |
4.33% |
Financial Strength
Liquidity I / Cash Ratio: |
30.57% |
Liquidity II / Quick Ratio: |
79.03% |
Liquidity III / Current Ratio: |
199.73% |
Debt / Equity Ratio: |
81.39% |
Dynam. Debt / Equity Ratio: |
778.53% |
Efficiency
Employees: |
- |
Personal Expenses / Employee: |
- USD |
Revenues / Employee: |
- USD |
Net Income / Employee: |
- USD |
Total Assets / Employee: |
- USD |
* Fiscal Year End: |
12/31/2023 |
Accounting Standard: |
US GAAP |